Peng W - Search Results

1

Hyperuricemia induces liver injury by upregulating HIF-1α and inhibiting arginine biosynthesis pathway in mouse liver and human L02 hepatocytes.

Huang L, He X, Peng W, He X, Xu B, Xu H, Wang Y, Xu W, Chen W, Wang S, Zhou L, Liu N, Xu Y, Lu W. Huang L, et al. Among authors: peng w. Biochem Biophys Res Commun. 2022 Aug 30;617(Pt 2):55-61. doi: 10.1016/j.bbrc.2022.05.096. Epub 2022 Jun 1. Biochem Biophys Res Commun. 2022. PMID: 35696777

2

#2714, a novel active inhibitor with potent G2/M phase arrest and antitumor efficacy in preclinical models.

Lu WJ, Peng W, Sun QQ, Li YH, Chen B, Yu LT, Xu YZ, Wang SY, Zhao YL. Lu WJ, et al. Among authors: peng w. Cell Death Discov. 2018 Feb 14;4:24. doi: 10.1038/s41420-018-0032-y. eCollection 2018 Dec. Cell Death Discov. 2018. PMID: 29531821 Free PMC article.

3

A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities.

Xu Y, Lu W, Yang P, Peng W, Wang C, Li M, Li Y, Li G, Meng N, Lin H, Kan L, Wang S, Yang S, Yu L, Zhao Y. Xu Y, et al. Among authors: peng w. BMC Cancer. 2015 Jul 18;15:525. doi: 10.1186/s12885-015-1451-2. BMC Cancer. 2015. PMID: 26187637 Free PMC article.

4

LC‑MS/MS metabolome analysis detects the changes in the lipid metabolic profiles of dMMR and pMMR cells.

Peng W, Tan S, Xu Y, Wang L, Qiu D, Cheng C, Lin Y, Liu C, Li Z, Li Y, Zhao Y, Li Q. Peng W, et al. Oncol Rep. 2018 Aug;40(2):1026-1034. doi: 10.3892/or.2018.6510. Epub 2018 Jun 20. Oncol Rep. 2018. PMID: 29989648

5

FUBP1 promotes the proliferation of lung squamous carcinoma cells and regulates tumor immunity through PD-L1.

Yu J, Peng W, Xue Y, Li Y, Yang L, Geng Y. Yu J, et al. Among authors: peng w. Allergol Immunopathol (Madr). 2022 Sep 1;50(5):68-74. doi: 10.15586/aei.v50i5.659. eCollection 2022. Allergol Immunopathol (Madr). 2022. PMID: 36086966

6

DNA-dependent protein kinase catalytic subunit inhibitor reverses acquired radioresistance in lung adenocarcinoma by suppressing DNA repair.

Li Y, Li H, Peng W, He XY, Huang M, Qiu D, Xue YB, Lu L. Li Y, et al. Among authors: peng w. Mol Med Rep. 2015 Jul;12(1):1328-34. doi: 10.3892/mmr.2015.3505. Epub 2015 Mar 18. Mol Med Rep. 2015. PMID: 25815686

7

Synergistic antitumor effect of 5-fluorouracil with the novel LSD1 inhibitor ZY0511 in colorectal cancer.

Peng W, Zhang H, Tan S, Li Y, Zhou Y, Wang L, Liu C, Li Q, Cen X, Yang S, Zhao Y. Peng W, et al. Ther Adv Med Oncol. 2020 Jul 23;12:1758835920937428. doi: 10.1177/1758835920937428. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32754230 Free PMC article.

8

Radiofrequency ablation versus laparoscopic hepatectomy for treatment of hepatocellular carcinoma: a systematic review and meta-analysis.

Jin S, Tan S, Peng W, Jiang Y, Luo C. Jin S, et al. Among authors: peng w. World J Surg Oncol. 2020 Aug 12;18(1):199. doi: 10.1186/s12957-020-01966-w. World J Surg Oncol. 2020. PMID: 32787883 Free PMC article. Review.

9

Enhancement of oxaliplatin-induced cell apoptosis and tumor suppression by 3-methyladenine in colon cancer.

Tan S, Peng X, Peng W, Zhao Y, Wei Y. Tan S, et al. Among authors: peng w, peng x. Oncol Lett. 2015 May;9(5):2056-2062. doi: 10.3892/ol.2015.2996. Epub 2015 Feb 27. Oncol Lett. 2015. PMID: 26137012 Free PMC article.

10

Taxus chinensis ameliorates diabetic nephropathy through down-regulating TGF-β1/Smad pathway.

Weng HB, Han WK, Xiong YW, Jin ZH, Lan Z, Liu C, Zhang XM, Peng W. Weng HB, et al. Among authors: peng w. Chin J Nat Med. 2018 Feb;16(2):90-96. doi: 10.1016/S1875-5364(18)30034-7. Chin J Nat Med. 2018. PMID: 29455733

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,412 results

Search Page

Filters